Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
SPECTRASCIENCE INC (SCIE) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/18/2017 8-K Quarterly results
11/08/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
07/16/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/18/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
11/13/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
10/22/2012 8-K Form 8-K - Current report
10/15/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
09/20/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
08/29/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
07/13/2012 8-K Form 8-K - Current report
06/21/2012 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "SpectraScience Signs Europe and Middle East Distribution Agreement with PENTAX for the WavSTAT Optical Biopsy System"
04/02/2012 8-K Form 8-K - Current report
03/16/2012 8-K Form 8-K - Current report
02/23/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
09/15/2011 8-K Form 8-K - Current report
07/18/2011 8-K Form 8-K - Current report
06/21/2011 8-K Investor presentation
Docs: "Company Presentation"
06/14/2011 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "2010 Letter to Shareholders"
03/01/2011 8-K Form 8-K - Current report
12/01/2010 8-K Form 8-K - Current report
10/25/2010 8-K Form 8-K - Current report
10/13/2010 8-K Form 8-K - Current report
06/24/2010 8-K Form 8-K - Current report
12/21/2009 8-K Form 8-K - Current report
11/05/2009 8-K Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Subscription Agreement",
"Form of Warrant",
"Certificate of Designation of Rights and Preferences of Series B Preferred Stock of SpectraScience, Inc"
08/04/2009 8-K Form 8-K - Current report
05/22/2009 8-K Form 8-K - Current report
02/04/2009 8-K Form 8-K -- Current report
05/02/2008 8-K Form 8-K -- Current report
12/11/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Jim Dorst joins SpectraScience as CFO December 10, 2007 San Diego, CA SpectraScience, Inc. announced today that Jim Dorst has joined the Company as its Vice President of Finance and Chief Financial Officer. Jim Hitchin the Company’s CEO said, “Jim comes to us with many years of experience in public medical device, manufacturing and software firms. His experience goes back to Coopers & Lybrand 25 years ago. With a graduate degree in accounting, he is well suited for SpectraScience as we grow.” SpectraScience has developed a multi-patented and proprietary WavSTAT TM Optical Biopsy System that is used by physicians to diagnose tissue to determine if it is normal, pre-cancerous, or cancerous within seconds. The WavSTAT TM System is currently approved by the FDA for use in detecting pre-cancer ..."
11/13/2007 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Acquisition Agreement",
"SpectraScience Acquires Luma Imaging Corporation November 8, 2007 San Diego, CA SpectraScience, Inc. announced today that it has acquired all of the shares of Luma Imaging Corporation. Luma™ has developed and received FDA approval for an optical non-invasive diagnostic imaging system that is proven to more effectively detect cervical cancer precursors than using conventional means alone . The Company’s LUMA™ Cervical Imaging System utilizes a single-use disposable probe and requires little additional training as it leverages clinicians’ existing skill sets. When used as an adjunct to colposcopy, LUMA™ detects significantly more high-grade cervical cancer precursors than colposcopy alone. Clinical trials comprised of over 3,000 women have demonstrated LUMA™’s ability..."
10/18/2007 8-K Other Events, Financial Statements and Exhibits
10/01/2007 8-K Financial Statements and Exhibits
Docs: "SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors"
06/25/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "PRESS RELEASE SpectraScience Appoints John Pappajohn to Board of Directors"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy